BioLight Raises $4.2M In Private Placement

March 20, 2014 | Israeli firm BioLight Israeli Life Sciences Investments, which invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, has announces the successful completion of a NIS 14.5 million (approx. $4.2 million) private placement. The investment was made by two unnamed institutional investors.